<DOC>
	<DOCNO>NCT01657136</DOCNO>
	<brief_summary>The aim study prospectively compare effectiveness safety ivabradine beta-blockers treatment inappropriate sinus tachycardia .</brief_summary>
	<brief_title>Ivabradine Versus Beta-blockers Treatment Inappropriate Sinus Tachycardia</brief_title>
	<detailed_description>Inappropriate sinus tachycardia ( IST ) non-paroxysmal arrhythmia , characterize persistently high sinus heart rate ( HR ) and/or exaggerate HR response minimal exertion , responsible palpitation , asthenia , chest pain , dizziness syncope , highly invalidate . Conventional treatment IST , target symptom control , mainly consist β-blockers . However , drug often insufficient well tolerated side effect ( mostly hypotension ) usually limit administer dose . Ivabradine , sinus rate lower agent currently employ Europe treatment stable angina chronic heart failure , recently demonstrate effective safe treatment IST case report clinical trial . A randomized clinical trial compare ivabradine β-blockers perform yet .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Sinus</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<criteria>Inappropriate sinus tachycardia ( HR &gt; 100 bpm rest ECG and/or medium Holter ECG HR &gt; 90 bpm ) Age &gt; 18 year ; Secondary cause sinus tachycardia ; Structural heart disease , Postural orthostatic tachycardia syndrome ; Sinus nodal reentrant tachycardia ; Contraindications betablockers ; Administration betablockers , nondihydropiridinic calcium channel antagonist , class I III antiarrhythmic drug digitalis time enrollment ; Age &lt; 18 year ; Inability give informed consent ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Inappropriate sinus tachycardia</keyword>
	<keyword>ivabradine</keyword>
	<keyword>beta blocker</keyword>
</DOC>